<p>Salem Investment Counselors Inc. 在最近向证券交易委员会提交的 13F 文件中表示，在第二季度将其在 CVS Health Corporation (NYSE:CVS - 免费报告) 的持股减少了 22.5%。该机构投资者在此期间出售了 14,135 股后，持有 48,751 股该药房运营商的股票。Salem Investment Counselors Inc. 在 CVS Health 的持股在最近一个季度末价值 3,363,000 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
<p>其他一些大型投资者也最近调整了对该公司的持股。Essex Financial Services Inc. 在第一季度将其在 CVS Health 的持股增加了 0.8%。Essex Financial Services Inc. 目前持有 20,705 股该药房运营商的股票，价值 1,403,000 美元，此前在上个季度购买了额外的 166 股。Hemington Wealth Management 在第一季度将其在 CVS Health 的持股增加了 33.7%。Hemington Wealth Management 目前持有 682 股该药房运营商的股票，价值 46,000 美元，此前在上个季度购买了额外的 172 股。McIlrath &amp; Eck LLC 在第四季度将其在 CVS Health 的持股增加了 32.6%。McIlrath &amp; Eck LLC 目前持有 707 股该药房运营商的股票，价值 32,000 美元，此前在上个季度购买了额外的 174 股。Sumitomo Life Insurance Co. 在第一季度将其在 CVS Health 的持股增加了 1.0%。Sumitomo Life Insurance Co. 目前持有 17,114 股该药房运营商的股票，价值 1,159,000 美元，此前在上个季度购买了额外的 174 股。最后，Koshinski Asset Management Inc. 在第一季度将其在 CVS Health 的持股增加了 3.7%。Koshinski Asset Management Inc. 目前持有 4,930 股该药房运营商的股票，价值 334,000 美元，此前在上个季度购买了额外的 178 股。当前 80.66% 的股票由机构投资者持有。</p>
<h2>CVS Health 股价上涨 0.4%</h2>
<p>CVS Health 股票周五开盘价为 75.00 美元。该股票的 50 日移动平均价格为 67.11 美元，200 日移动平均价格为 66.32 美元。CVS Health Corporation 的一年低点为 43.56 美元，一年高点为 75.55 美元。该公司的市值为 951.2 亿美元，市盈率为 20.95，市盈增长比率为 0.82，贝塔值为 0.62。该公司的债务与股本比率为 0.74，流动比率为 0.80，速动比率为 0.62。</p>
<ul>
<li>现在是买入诺和诺德股票的好时机吗？</li>
</ul>
<p>CVS Health (NYSE:CVS - 获取免费报告) 最近于 7 月 31 日星期四公布了季度财报。该药房运营商报告每股收益为 1.81 美元，超出市场共识预期的 1.46 美元，超出 0.35 美元。CVS Health 的股本回报率为 10.51%，净利润率为 1.17%。该公司在本季度的收入为 989.2 亿美元，而分析师预期为 948.7 亿美元。去年同期，该公司每股收益为 1.83 美元。该公司的季度收入同比增长 8.4%。CVS Health 已将其 2025 财年的指引设定为每股收益 6.300-6.400。股票研究分析师预计 CVS Health Corporation 本年度将发布每股收益 5.89 美元。</p>
<h2>CVS Health 宣布分红</h2>
<p>该公司最近还披露了季度分红，该分红于 8 月 1 日星期五支付。7 月 22 日的登记投资者获得了 0.665 美元的分红。该分红的除息日为 7 月 22 日。这代表着年化分红为 2.66 美元，收益率为 3.5%。CVS Health 的分红支付比率 (DPR) 为 74.30%。</p>
<h2>分析师评级上调与下调</h2>
<ul>
<li>在业绩疲软和 CVS-诺和诺德合作后，艾利利是买入吗？</li>
</ul>
<p>几家券商对 CVS 进行了评估。Baird R W 在 8 月 14 日星期四的研究报告中将 CVS Health 的评级从 “持有” 上调至 “强力买入”。Jefferies Financial Group 在 6 月 30 日星期一的研究报告中将 CVS Health 的目标价从 74.00 美元上调至 80.00 美元，并给予该公司 “买入” 评级。UBS Group 在 8 月 18 日星期一的研究报告中将 CVS Health 的评级从 “中性” 上调至 “买入”，并将该公司的目标价从 67.00 美元上调至 79.00 美元。Bernstein Bank 在 7 月 16 日星期三的研究报告中将 CVS Health 的目标价从 78.00 美元下调至 72.00 美元，并对该股票设定了 “市场表现” 评级。最后，Cowen 在 8 月 4 日星期一的研究报告中重申了对 CVS Health 股票的 “买入” 评级。两位研究分析师对该股票给予了强力买入评级，十九位给予了买入评级，三位对该股票给予了持有评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，平均目标价为 77.89 美元。</p>
<p><strong>查看我们对 CVS 的最新分析</strong></p>
<h2>内部人士下注</h2>
<p>在相关消息中，董事 Anne A. Finucane 于 8 月 20 日星期三出售了 7,500 股 CVS Health 股票。该股票以平均价格 71.02 美元出售，总价值为 532,650.00 美元。出售完成后，该董事持有 22,156 股公司股票，价值约 1,573,519.12 美元。此交易代表其持股减少了 25.29%。该出售在向 SEC 的法律文件中披露，可以通过此超链接访问。公司内部人士持有公司股票的 1.22%。</p>
<h2>关于 CVS Health</h2>
<p>(免费报告)</p>
<p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房与消费者健康三个部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
<h2>推荐故事</h2>
<ul>
<li>我们更看好的五只股票，而不是 CVS Health</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>乘着奢侈零售浪潮，这三只高端品牌股票值得关注</li>
<li>低市盈率成长股：发掘投资机会</li>
<li>华尔街悄然看好这些中国科技巨头</li>
<li>为什么投资 5G？如何投资 5G 股票</li>
<li>Meta 的 6000 亿美元美国投资：对股票是看跌还是看涨？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快速和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在 CVS Health 吗？</h2>
<p>在你考虑 CVS Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中有中性买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

<p>根据最近的 SEC 文件，Salem Investment Counselors Inc.在第二季度减少了对 CVS Health Corporation 的持股比例，减持了 22.5%，出售了 14,135 股。出售后，该公司持有 48,751 股，估值约为 336 万美元。其他机构投资者也调整了他们在 CVS 的持股。该股票开盘价为 75.00 美元，市值为 951.2 亿美元，市盈率为 20.95。CVS 最近报告每股收益为 1.81 美元，超出预期，并宣布季度股息为 0.665 美元</p>

<p>Salem Investment Counselors Inc. reduced its position in CVS Health Corporation (NYSE:CVS - Free Report) by 22.5% during the second quarter, according to the company in its most recent 13F filing with the Securities &amp; Exchange Commission. The institutional investor owned 48,751 shares of the pharmacy operator's stock after selling 14,135 shares during the period. Salem Investment Counselors Inc.'s holdings in CVS Health were worth $3,363,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Salem Investment Counselors Inc. 在最近向证券交易委员会提交的 13F 文件中表示，在第二季度将其在 CVS Health Corporation (NYSE:CVS - 免费报告) 的持股减少了 22.5%。该机构投资者在此期间出售了 14,135 股后，持有 48,751 股该药房运营商的股票。Salem Investment Counselors Inc. 在 CVS Health 的持股在最近一个季度末价值 3,363,000 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
</div><p>A number of other large investors also recently modified their holdings of the company. Essex Financial Services Inc. lifted its holdings in shares of CVS Health by 0.8% in the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after purchasing an additional 166 shares in the last quarter. Hemington Wealth Management lifted its holdings in shares of CVS Health by 33.7% in the 1st quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator's stock worth $46,000 after purchasing an additional 172 shares in the last quarter. McIlrath &amp; Eck LLC lifted its holdings in shares of CVS Health by 32.6% in the 4th quarter. McIlrath &amp; Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after purchasing an additional 174 shares in the last quarter. Sumitomo Life Insurance Co. lifted its holdings in shares of CVS Health by 1.0% in the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock worth $1,159,000 after purchasing an additional 174 shares in the last quarter. Finally, Koshinski Asset Management Inc. lifted its holdings in shares of CVS Health by 3.7% in the 1st quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock worth $334,000 after purchasing an additional 178 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他一些大型投资者也最近调整了对该公司的持股。Essex Financial Services Inc. 在第一季度将其在 CVS Health 的持股增加了 0.8%。Essex Financial Services Inc. 目前持有 20,705 股该药房运营商的股票，价值 1,403,000 美元，此前在上个季度购买了额外的 166 股。Hemington Wealth Management 在第一季度将其在 CVS Health 的持股增加了 33.7%。Hemington Wealth Management 目前持有 682 股该药房运营商的股票，价值 46,000 美元，此前在上个季度购买了额外的 172 股。McIlrath &amp; Eck LLC 在第四季度将其在 CVS Health 的持股增加了 32.6%。McIlrath &amp; Eck LLC 目前持有 707 股该药房运营商的股票，价值 32,000 美元，此前在上个季度购买了额外的 174 股。Sumitomo Life Insurance Co. 在第一季度将其在 CVS Health 的持股增加了 1.0%。Sumitomo Life Insurance Co. 目前持有 17,114 股该药房运营商的股票，价值 1,159,000 美元，此前在上个季度购买了额外的 174 股。最后，Koshinski Asset Management Inc. 在第一季度将其在 CVS Health 的持股增加了 3.7%。Koshinski Asset Management Inc. 目前持有 4,930 股该药房运营商的股票，价值 334,000 美元，此前在上个季度购买了额外的 178 股。当前 80.66% 的股票由机构投资者持有。</p>
</div><h2>CVS Health Trading Up 0.4%</h2>
<div class="lb-trans"><h2>CVS Health 股价上涨 0.4%</h2>
</div><p>Shares of CVS Health stock opened at $75.00 on Friday. The stock has a fifty day moving average price of $67.11 and a 200-day moving average price of $66.32. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $75.55. The firm has a market cap of $95.12 billion, a PE ratio of 20.95, a P/E/G ratio of 0.82 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.</p>
<div class="lb-trans"><p>CVS Health 股票周五开盘价为 75.00 美元。该股票的 50 日移动平均价格为 67.11 美元，200 日移动平均价格为 66.32 美元。CVS Health Corporation 的一年低点为 43.56 美元，一年高点为 75.55 美元。该公司的市值为 951.2 亿美元，市盈率为 20.95，市盈增长比率为 0.82，贝塔值为 0.62。该公司的债务与股本比率为 0.74，流动比率为 0.80，速动比率为 0.62。</p>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>现在是买入诺和诺德股票的好时机吗？</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same quarter last year, the firm posted $1.83 EPS. The firm's revenue for the quarter was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.</p>
<div class="lb-trans"><p>CVS Health (NYSE:CVS - 获取免费报告) 最近于 7 月 31 日星期四公布了季度财报。该药房运营商报告每股收益为 1.81 美元，超出市场共识预期的 1.46 美元，超出 0.35 美元。CVS Health 的股本回报率为 10.51%，净利润率为 1.17%。该公司在本季度的收入为 989.2 亿美元，而分析师预期为 948.7 亿美元。去年同期，该公司每股收益为 1.83 美元。该公司的季度收入同比增长 8.4%。CVS Health 已将其 2025 财年的指引设定为每股收益 6.300-6.400。股票研究分析师预计 CVS Health Corporation 本年度将发布每股收益 5.89 美元。</p>
</div><h2>CVS Health Announces Dividend</h2>
<div class="lb-trans"><h2>CVS Health 宣布分红</h2>
</div><p>The company also recently disclosed a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, July 22nd. This represents a $2.66 annualized dividend and a yield of 3.5%. CVS Health's dividend payout ratio (DPR) is 74.30%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，该分红于 8 月 1 日星期五支付。7 月 22 日的登记投资者获得了 0.665 美元的分红。该分红的除息日为 7 月 22 日。这代表着年化分红为 2.66 美元，收益率为 3.5%。CVS Health 的分红支付比率 (DPR) 为 74.30%。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><ul>
<li>Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?</li>
</ul>
<div class="lb-trans"><ul>
<li>在业绩疲软和 CVS-诺和诺德合作后，艾利利是买入吗？</li>
</ul>
</div><p>Several brokerages have weighed in on CVS. Baird R W upgraded CVS Health from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Thursday, August 14th. Jefferies Financial Group raised their price objective on CVS Health from $74.00 to $80.00 and gave the company a &#34;buy&#34; rating in a research note on Monday, June 30th. UBS Group upgraded CVS Health from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their price objective for the company from $67.00 to $79.00 in a research note on Monday, August 18th. Bernstein Bank dropped their price objective on CVS Health from $78.00 to $72.00 and set a &#34;market perform&#34; rating on the stock in a research note on Wednesday, July 16th. Finally, Cowen restated a &#34;buy&#34; rating on shares of CVS Health in a research note on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $77.89.</p>
<div class="lb-trans"><p>几家券商对 CVS 进行了评估。Baird R W 在 8 月 14 日星期四的研究报告中将 CVS Health 的评级从 “持有” 上调至 “强力买入”。Jefferies Financial Group 在 6 月 30 日星期一的研究报告中将 CVS Health 的目标价从 74.00 美元上调至 80.00 美元，并给予该公司 “买入” 评级。UBS Group 在 8 月 18 日星期一的研究报告中将 CVS Health 的评级从 “中性” 上调至 “买入”，并将该公司的目标价从 67.00 美元上调至 79.00 美元。Bernstein Bank 在 7 月 16 日星期三的研究报告中将 CVS Health 的目标价从 78.00 美元下调至 72.00 美元，并对该股票设定了 “市场表现” 评级。最后，Cowen 在 8 月 4 日星期一的研究报告中重申了对 CVS Health 股票的 “买入” 评级。两位研究分析师对该股票给予了强力买入评级，十九位给予了买入评级，三位对该股票给予了持有评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，平均目标价为 77.89 美元。</p>
</div><p><strong>View Our Latest Analysis on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我们对 CVS 的最新分析</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company's stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.22% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，董事 Anne A. Finucane 于 8 月 20 日星期三出售了 7,500 股 CVS Health 股票。该股票以平均价格 71.02 美元出售，总价值为 532,650.00 美元。出售完成后，该董事持有 22,156 股公司股票，价值约 1,573,519.12 美元。此交易代表其持股减少了 25.29%。该出售在向 SEC 的法律文件中披露，可以通过此超链接访问。公司内部人士持有公司股票的 1.22%。</p>
</div><h2>About CVS Health</h2>
<div class="lb-trans"><h2>关于 CVS Health</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房与消费者健康三个部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>How to Effectively Use the MarketBeat Ratings Screener</li>
<li>Ride the Luxury Retail Wave with These 3 High-End Brand Stocks</li>
<li>Low PE Growth Stocks: Unlocking Investment Opportunities</li>
<li>Wall Street Quietly Bets Big on These Chinese Tech Giants</li>
<li>Why Invest in 5G? How to Invest in 5G Stocks</li>
<li>Meta's $600B U.S. Investment: Bearish or Bullish for Shares?</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 CVS Health</li>
<li>如何有效使用 MarketBeat 评级筛选器</li>
<li>乘着奢侈零售浪潮，这三只高端品牌股票值得关注</li>
<li>低市盈率成长股：发掘投资机会</li>
<li>华尔街悄然看好这些中国科技巨头</li>
<li>为什么投资 5G？如何投资 5G 股票</li>
<li>Meta 的 6000 亿美元美国投资：对股票是看跌还是看涨？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快速和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 CVS Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中有中性买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Salem Investment Counselors Inc. 出售了 14,135 股西维斯的股票